期刊文献+

RAPD用于新生儿病房产气肠杆菌分子流行病学研究 被引量:1

RAPD Applied to Molecular Epidemiology of Enterobacter aerogenes in a Neonatal Unit
暂未订购
导出
摘要 目的建立产气肠杆菌RAPD技术,用于新生儿病房产气肠杆菌分子流行病学研究。方法在具有10张床位的新生儿病房,于同一时间采自4例同期住院患儿分离出5株产气肠杆菌,做RAPD分析及药敏试验,找出流行相关菌株及分析耐药情况。结果两株具有相同RAPD指纹图谱的产气肠杆菌是流行相关菌株,分别采自住院第4天和第10天的两例患儿,在新生儿病房内获得;所有菌株不同程度地对氨基苷类、哌拉西林、三代头孢菌素耐药。结论RAPD技术为产气肠杆菌分子流行病学研究提供了简便、可靠的手段,菌株的耐药情况可能与标本采集之前抗菌药物的应用有关。 OBJECTIVE To establish RAPD typing method for Enterobacter aerogenes, and apply RAPD to study molecular epidemiology of E. aerogenes in a neonatal unit. METHODS Five E. aerogenes strains were isolated from four patients in the same neonatal unit at the same time. These strains were typed by RAPD technique. Antibiotic susceptibility was determined by MIC to evaluate drug-resistance. RESULTS Two strains belonging to a unique RAPD-typed ones were epidemiologically related strains. These strains isolated from two patients who hospitalized in the same neonatal unit for four and ten days, respectively. Five E. aerogenes strains were resistant to aminoglycosides, piperacillin and the third-generation cephalosporins in varying degree. CONCLUSIONS RAPD technique is a very easy and reliable molecular tool in the study of E. aerogenes epidemiology. Antibiotic resistance of E. aerogenes is probably related with the history of using antibiotics.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2007年第4期475-477,共3页 Chinese Journal of Nosocomiology
关键词 RAPD 新生儿 产气肠杆菌 分子流行病学 分型 RAPD Neonate Enterobacteraerogene Molecular epidemiology Typing
  • 相关文献

参考文献5

二级参考文献8

  • 1Van Belkum A, Kluytmans J, van Leeuwen W, et al. Multi-center evaluation of arbitrarily primed PCR for typing of Staphylococcus aureus strains [J]. Clin Microbiol, 1995, 33(6): 1547.
  • 2Bingen E, Boissinot C, Desjardins P, et al. Arbitrarily primed polymerase chain reaction provides rapid differentiation of Pro-teus mirabilis isolates from a pediatric hospital[J]. Clin Miro-biol, 1993, 3l(5).1055-1059.
  • 3Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes[J], J Antimicrob Chemother(England), 2001,48,Suppl I, 87-102.
  • 4National Committee for Clinical Laboratory Standards. MIC testing supplement tables. M100-S13(M7).[S]. NCCLS, 2003.
  • 5Xu YC, Chen MJ, Douglas J, et al. Evaluation of the in vitro antimicrobial activity of cefepime compared to other broad-spectrum beta-lactams tested against recent clinical isolates from 10 Chinese hospitals[J]. Diagn Microbial Infect Dis,1999,35(2):135-1
  • 6Joshi M, Brull R, Sompali N, et al. Clinical outcomes of cefepime treatment on infections caused by ESBLs-and AmpC-producing Enterobacteriaceae[A]. 40th ICAAC, Abstract. 2000. 426.
  • 7王军,于玺华,徐桂永,李伯安,王全立,李永刚,姜天俊,李元治.O139、O1群霍乱弧菌分子遗传特征研究[J].中华传染病杂志,1999,17(2):82-84. 被引量:12
  • 8鲍长途,王光,孙利炜,李永富,焦立新,赵含章.随机扩增多态DNA指纹技术的研究及在检测医院感染中的应用[J].中华医院感染学杂志,2000,10(2):97-99. 被引量:5

共引文献15

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部